Pooled week 48 safety and efficacy results from the ECHO and THRIVE phase III trials comparing TMC278 vs EFV in treatment-naïve, HIV-1-infected patients

Detalles Bibliográficos
Autores principales: Cohen, C, Molina, JM, Cahn, P, Clotet, B, Fourie, J, Grinsztejn, B, Hao, W, Johnson, M, Supparatpinyo, K, Crauwels, HM, Rimsky, L, Vanveggel, S, Williams, P, Boven, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2010
Materias:
Oral Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112863/
http://dx.doi.org/10.1186/1758-2652-13-S4-O48

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112863/
http://dx.doi.org/10.1186/1758-2652-13-S4-O48

Ejemplares similares